Sunshine Biopharma, Inc. (SBFM) Earnings History
Annual and quarterly earnings data from 2007 to 2024
Loading earnings history...
SBFM EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
SBFM Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 30.6% | -16.7% | -14.7% |
| 2023 | 34.6% | -19.9% | -18.7% |
| 2022 | 39.0% | -621.3% | -615.4% |
| 2021 | 48.4% | -1068.2% | -5444.2% |
| 2020 | 63.8% | -807.8% | -3898.7% |
Download Data
Export SBFM earnings history in CSV or JSON format
Free sign-in required to download data
Sunshine Biopharma, Inc. (SBFM) Earnings Overview
As of May 8, 2026, Sunshine Biopharma, Inc. (SBFM) reported trailing twelve-month net income of -$6M, reflecting +97.9% year-over-year growth. The company earned $-28.05 per diluted share over the past four quarters, with a net profit margin of -14.7%.
Looking at the long-term picture, SBFM's historical earnings data spans multiple years. The company achieved its highest annual net income of $0 in fiscal 2009.
Sunshine Biopharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CRVS (-$44M net income), IMVT (-$464M net income), NUVB (-$146M net income, -325.3% margin), SBFM has comparable earnings metrics. Compare SBFM vs CRVS →
SBFM Earnings vs Peers
Earnings metrics vs comparable public companies
SBFM Historical Earnings Data (2007–2024)
18 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$5M | -13.9% | -$6M | $-7.32 | -14.7% | -16.7% |
| 2023 | -$5M | +83.2% | -$5M | $-351.36 | -18.7% | -19.9% |
| 2022 | -$27M | -115.1% | -$27M | $-3523.64 | -615.4% | -621.3% |
| 2021 | -$12M | -346.7% | -$2M | $-9520.00 | -5444.2% | -1068.2% |
| 2020 | -$3M | -67.7% | $-576,874 | $-3214.89 | -3898.7% | -807.8% |
| 2019 | -$2M | +23.0% | $-641,636 | $-18866.94 | -7860.9% | -3037.9% |
| 2018 | -$2M | -107.3% | -$1M | $-142.00 | -482.1% | -261.0% |
| 2017 | -$1M | +70.3% | $-857,190 | $-23.84 | - | - |
| 2016 | -$3M | -111.5% | $-993,108 | $-164.63 | - | - |
| 2015 | -$2M | +14.5% | $-780,000 | $-999999.00 | -96779.9% | -45667.4% |
See SBFM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SBFM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SBFM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSBFM — Frequently Asked Questions
Quick answers to the most common questions about buying SBFM stock.
Is SBFM growing earnings?
SBFM EPS is $-28.05, with earnings growth accelerating to +97.9%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-6M.
What are SBFM's profit margins?
Sunshine Biopharma, Inc. net margin is -14.7%, with operating margin at -16.7%. Below-average margins reflect competitive or cost pressures.
How consistent are SBFM's earnings?
SBFM earnings data spans 2007-2024. The accelerating earnings trend is +97.9% YoY. Historical data enables comparison across business cycles.